Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancers|May 7, 2020
Multi-Gene Prognostic Signatures and Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in ER-positive, HER2-negative Breast Cancer PatientsClaudia Mazo, Stephen Barron, Catherine Mooney, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|November 13, 2009
Reliability and acceptance of the mini-clinical evaluation exercise as a performance assessment of practicing physiciansRavi S Sidhu, Rose Hatala, Stephen Barron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 24, 2019
Validation of the OncoMasTR Risk Score in Estrogen Receptor-Positive/HER2-Negative Patients: A TransATAC studyRichard Buus, Ivana Sestak, Stephen Barron, et al.
BJUI Compass|January 29, 2025
Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancerAgnieszka Krzyzanowska, Debra F Higgins, Stephen Barron, et al.
European Urology Focus|April 27, 2023
Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate CancerAgnieszka Krzyzanowska, Stephen Barron, Debra F Higgins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2021
The OncoMasTR Test Predicts Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative Early-Stage Breast Cancer: A Validation Study in ABCSG Trial 8Martin Filipits, Margaretha Rudas, Verena Kainz, et al.
Clinical Chemistry|March 21, 2022
Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast CancerTony Loughman, Stephen Barron, Chan-Ju Angel Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2021
Prognostic value of the 6-gene OncoMasTR test in hormone receptor-positive HER2-negative early-stage breast cancer: Comparative analysis with standard clinicopathological factorsSeodhna M Lynch, Niamh M Russell, Stephen Barron, et al.
Pageof 1